IP Library Granted Patent US 8,168,658
Granted Patent B2
US 8,168,658 · App. 12/224,466 · Granted May 1, 2012

Inhibitors of histone deacetylase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,168,658
App. No.
12/224,466
Granted
May 1, 2012
Kind
B2
Abstract

The present invention relates to a novel class of compounds. These compounds can inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases. The present invention further provides pharmaceutical compositions comprising the compounds of the instant invention and safe dosing regimens of these pharmaceutical compositions, which are easy to follow, and which result in a therapeutically effective amount of these compounds in vivo.

Claims (238)

1. A compound represented by Formula I:

wherein

X is 1) —(CR 2 2 ) n C(O)OR 1 ,

2) —(CR 2 2 ) n C(O)NR 1 2 ,

3) —(CR 2 2 ) n C(O)R 1 ,

4) —(CR 2 2 ) n OC(O)NR 1 2 ,

5) —(CR 2 2 ) n aryl, wherein aryl is optionally substituted with one or more substituents,

6) —(CR 2 2 ) n C(O)NR 1 (CR 2 2 ) m NR 1 2 ,

7) —(CR 2 2 ) n C(O)NR 1 (CR 2 2 ) m NR 1 C(O)R 1 ,

8) —(CR 2 2 ) n C(O)NR 1 (CR 2 2 ) n OR 1 , or

9) —(CR 2 2 ) n C(O)NR 1 (CR 2 2 ) n C(O)NR 1 2 ;

Y is unsubstituted or substituted aryl or unsubstituted or substituted thienyl or pyridinyl;

Z is aryl or heteroaryl;

R is H or unsubstituted or substituted C 1 -C 6 alkyl;

R 1 is independently selected from H, C 1 -C 6 alkyl, —(CR 2 2 ) n aryl, and —(CR 2 2 ) n heterocyclyl;

wherein said alkyl, aryl or heterocyclyl is optionally substituted with one or more substituents;

R 2 and R 3 are independently selected from H, unsubstituted or substituted C 1 -C 6 alkyl, and (CR 2 2 ) n aryl;

R 4 is

1) —(CR 2 2 ) n NR 5 2 ,

2) —(CR 2 2 ) n NR 5 C(O)R 5 ,

3) —(CR 2 2 ) n NR 5 C(O)OR 5 ,

4) —(CR 2 2 ) n heterocyclyl,

5) —(CR 2 2 ) n NR 5 S(O) 2 R 5 , or

6) —(CR 2 2 ) n NR 5 C(O)NR 5 2 ;

wherein heterocyclyl is optionally substituted with one or more substituents;

optionally, when R is unsubstituted or substituted C 1 -C 6 alkyl and R 4 is not —(CR 2 2 ) n heterocyclyl, R and R 4 may be cyclized to form a ring system;

R 5 is independently selected from H, C 1 -C 6 alkyl, —(CR 2 2 ) n aryl, and —(CR 2 2 ) n heterocyclyl, wherein alkyl, aryl or heterocyclyl may be optionally substituted with one or more substituents;

R 8 is unsubstituted or substituted aryl or unsubstituted or substituted heteroaryl;

R 12 is NH 2 , NR 5 C(O)R 5 , NR 5 C(O)OR 5 , OH, or NH-Boc;

m is 1, 2 or 3;

n is independently 0, 1, 2, 3 or 4;

p is 0, 1, 2, 3, or 4;

s is 0, 1 or 2;

or a stereoisomer or a pharmaceutically acceptable salt thereof.

2. The compound according to claim 1 , wherein

Y is phenyl, thienyl, or pyridinyl, wherein phenyl, thienyl or pyridinyl is optionally substituted with one or two substituents selected from R 7 ;

Z is phenyl, pyrazolyl, thienyl or pyridinyl;

R 2 and R 3 are independently selected from H and unsubstituted or substituted C 1 -C 6 alkyl;

R 7 is independently selected from unsubstituted or substituted C 1 -C 6 alkyl, OR 5 , —(CR 2 2 ) n aryl, CN, CF 3 and halo;

or a stereoisomer or a pharmaceutically acceptable salt thereof.

3. The compound according to claim 1 , represented by Formula II

wherein

X is 1) —(CR 2 2 ) n C(O)OR 1 ,

2) —(CR 2 2 ) n C(O)NR 1 2 ,

3) —(CR 2 2 ) n C(O)R 1 ,

4) —(CR 2 2 ) n OC(O)NR 1 2 ,

5) —(CR 2 2 ) n aryl, wherein aryl is optionally substituted with one to three substituent selected from R 7 ,

6) —(CR 2 2 ) n C(O)NR 1 (CR 2 2 ) m NR 1 2 ,

7) —(CR 2 2 ) n C(O)NR 1 (CR 2 2 ) m NR 1 C(O)R 1 ,

8) —(CR 2 2 ) n C(O)NR 1 (CR 2 2 ) n OR 1 , or

9) —(CR 2 2 ) n C(O)NR 1 (CR 2 2 ) n C(O)NR 1 2 ;

Z is phenyl or pyrazolyl;

R is H or unsubstituted or substituted C 1 -C 6 alkyl;

R 1 is independently selected from H, C 1 -C 6 alkyl, —(CR 2 2 ) n aryl, and —(CR 2 2 ) n heterocyclyl;

wherein said alkyl, aryl or heterocyclyl is optionally substituted with one to three substituent selected from R 7 ;

R 2 and R 3 are independently selected from H, unsubstituted or substituted C 1 -C 6 alkyl, and (CR 2 2 ) n aryl;

R 4 is

1) —(CR 2 2 ) n NR 5 2 ,

2) —(CR 2 2 ) n NR 5 C(O)R 5 ,

3) —(CR 2 2 ) n NR 5 C(O)OR 5 ,

4) —(CR 2 2 ) n heterocyclyl,

5) —(CR 2 2 ) n NR 5 S(O) 2 R 5 , or

6) —(CR 2 2 ) n NR 5 C(O)NR 5 2 ;

wherein heterocyclyl is optionally substituted with one to three substituent selected from R 7 ;

R 5 is independently selected from H, C 1 -C 6 alkyl, —(CR 2 2 ) n aryl, and —(CR 2 2 ) n heterocyclyl, wherein alkyl, aryl or heterocyclyl may be optionally substituted with one to three substituent selected from R 7 ;

R 7 is independently selected from unsubstituted or substituted C 1 -C 6 alkyl, OR 5 , —(CR 2 2 ) n aryl, CN, CF 3 and halo;

R 8 is unsubstituted or substituted phenyl or unsubstituted or substituted thienyl;

R 12 is NH 2 , OH, or NH-Boc;

m is 1, 2 or 3;

n is independently 0, 1, 2, 3 or 4;

p is 0, 1, 2, or 3;

s is 0, or 1;

or a stereoisomer or a pharmaceutically acceptable salt thereof.

4. The compound according to claim 1 , represented by Formula III

wherein

X is 1) —(CR 2 2 ) n C(O)OR 1 ,

2) —(CR 2 2 ) n C(O)NR 1 2 ,

3) —(CR 2 2 ) n C(O)R 5 , or

4) —(CR 2 2 ) n aryl, wherein aryl is optionally substituted with one to three substituent selected from R 7 ;

R is H or unsubstituted or substituted C 1 -C 6 alkyl;

R 1 is independently selected from H, C 1 -C 6 alkyl, —(CR 2 2 ) n aryl, and —(CR 2 2 ) n heterocyclyl;

wherein said alkyl, aryl or heterocyclyl is optionally substituted with one to three substituent selected from R 7 ;

R 2 and R 3 are independently selected from H, unsubstituted or substituted C 1 -C 6 alkyl, and (CR 2 2 ) n aryl;

R 4 is

1) —(CR 2 2 ) n NR 5 2 ,

2) —(CR 2 2 ) n NR 5 C(O)R 5 ,

3) —(CR 2 2 ) n NR 5 C(O)OR 5 ,

4) —(CR 2 2 ) n heterocyclyl,

5) —(CR 2 2 ) n NR 5 S(O) 2 R 5 , or

6) —(CR 2 2 ) n NR 5 C(O)NR 5 2 ;

wherein heterocyclyl is optionally substituted with one to three substituent selected from R 7 ;

R 5 is independently selected from H, C 1 -C 6 alkyl, —(CR 2 2 ) n aryl, and —(CR 2 2 ) n heterocyclyl, wherein alkyl, aryl or heterocyclyl may be optionally substituted with one to three substituent selected from R 7 ;

R 7 is independently selected from unsubstituted or substituted C 1 -C 6 alkyl, OR 5 , —(CR 2 2 ) n aryl, CN, CF 3 and halo;

R 8 is phenyl or thienyl;

R 12 is NH 2 ;

n is independently 0, 1, 2, 3 or 4;

p is 0, 1, 2, or 3;

or a stereoisomer or a pharmaceutically acceptable salt thereof.

5. The compound of claim 1 selected from

amino[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]acetic acid;

ethyl amino[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]acetate;

4-[1-amino-2-(methylamino)-2-oxoethyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

N-[2-amino-5-(2-thienyl)phenyl]-4-(1,2-diamino-2-oxoethyl)benzamide;

4-{1-amino-2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-{1-amino-2-[(2-methoxyphenyl)amino]-2-oxoethyl}-N-(4-amino-1-phenyl-1H-pyrazol-3-yl)benzamide;

4-[1-amino-2-(isoxazol-3-ylamino)-2-oxoethyl]-N-(4-amino-1-phenyl-1H-pyrazol-3-yl)benzamide;

4-[1-amino-2-oxo-2-(pyridin-2-ylamino)ethyl]-N-(4-amino-1-phenyl-1H-pyrazol-3-yl)benzamide;

4-{1-amino-2-[(4-methyl-1,3-thiazol-2-yl)amino]-2-oxoethyl}-N-(4-amino-1-phenyl-1H-pyrazol-3-yl)benzamide;

4-{1-amino-2-[(3-methoxyphenyl)amino]-2-oxoethyl}-N-(4-amino-1-phenyl-1H-pyrazol-3-yl)benzamide;

4-{1-amino-2-[(4-cyanopyridin-2-yl)amino]-2-oxoethyl}-N-(4-amino-1-phenyl-1H-pyrazol-3-yl)benzamide;

4-[1-amino-2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxoethyl]-N-(4-amino-1-phenyl-1H-pyrazol-3-yl)benzamide;

ethyl [4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]{[(pyridin-3-ylmethoxy)carbonyl]amino}acetate;

[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]{[(pyridin-3-ylmethoxy)carbonyl]amino}acetic acid;

pyridin-3-ylmethyl [1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]-2-(methylamino)-2-oxoethyl]carbamate;

pyridin-3-ylmethyl {2-amino-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino} carbonyl)phenyl]-2-oxoethyl}carbamate;

pyridin-3-ylmethyl [1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]-2-(ethylamino)-2-oxoethyl]carbamate;

pyridin-3-ylmethyl [1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]-2-(isopropylamino)-2-oxoethyl]carbamate;

pyridin-3-ylmethyl [1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]-2-(dimethylamino)-2-oxoethyl]carbamate;

(acetylamino)[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]acetic acid;

4-[1-(acetylamino)-2-oxo-2-pyrrolidin-1-ylethyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-[1-(acetylamino)-2-amino-2-oxoethyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-[1-(acetylamino)-2-(methylamino)-2-oxoethyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-[1-(acetylamino)-2-(dimethylamino)-2-oxoethyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-[1-(acetylamino)-2-(isopropylamino)-2-oxoethyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-[1-(acetylamino)-2-(ethylamino)-2-oxoethyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

Tert-butyl [2-({4-[1-(acetylamino)-2-(methylamino)-2-oxoethyl]benzoyl}amino)-4-(2-thienyl)phenyl] carbamate;

N-[2-amino-5-(2-thienyl)phenyl]-4-[2-(methylamino)-2-oxo-1-pyrrolidin-1-ylethyl]benzamide;

[4-({[2-amino-5-(2-thienyl)phenyl] amino}carbonyl)phenyl](pyrrolidin-1-yl)acetic acid;

N-[2-amino-5-(2-thienyl)phenyl]-4-[2-(isopropylamino)-1-(4-methylpiperidin-1-yl)-2-oxoethyl]benzamide;

N-(2-amino-5-thien-2-ylphenyl)-4-{1-azetidin-1-yl-2-[(4-methylphenyl)amino]-2-oxoethyl}benzamide;

N-(2-amino-5-thien-2-ylphenyl)-4-[1-(diethylamino)-2-(isopropylamino)-2-oxoethyl]benzamide;

N-(2-amino-5-thien-2-ylphenyl)-4-[1-azetidin-1-yl-2-(isopropylamino)-2-oxoethyl]benzamide;

N-(2-amino-5-thien-3-ylphenyl)-5-[2-[(4-chlorophenyl)amino]-1-(4-methylpiperazin-1-yl)-2-oxoethyl]thiophene-2-carboxamide;

N-(2-amino-5-thien-2-ylphenyl)-5-[2-[(4-chlorophenyl)amino]-1-(4-methylpiperazin-1-yl)-2-oxoethyl]thiophene-2-carboxamide;

N-(2-aminophenyl)-4-[1-(benzoylamino)-2-(benzylamino)-2-oxoethyl]benzamide;

N-(2-aminophenyl)-4-[1,2-bis(benzylamino)-2-oxoethyl]benzamide;

N-(2-aminophenyl)-4-{2-(benzylamino)-2-oxo-1-[(2-phenylethyl)amino]ethyl Benzamide;

N-(2-aminophenyl)-4-{1-(benzoylamino)-2-[(4-chlorophenyl)amino]-2-oxoethyl}benzamide;

N-(2-aminophenyl)-4-{2-[(4-chlorophenyl)amino]-2-oxo-1-[(phenylacetyl)amino]ethyl}benzamide;

N-(2-aminophenyl)-4-{2-[(4-chlorophenyl)amino]-2-oxo-1-[(3-phenylpropanoyl)amino]ethyl}benzamide;

N-(2-aminophenyl)-4-{1-(benzoylamino)-2-[(4-methylphenyl)amino]-2-oxoethyl}benzamide;

N-(2-aminophenyl)-4-[1-(benzoylamino)-2-(2-naphthylamino)-2-oxoethyl]benzamide;

N-(2-aminophenyl)-4-{2-[(4-methylphenyl)amino]-2-oxo-1-[(phenylacetyl)amino]ethyl}benzamide;

N-(2-aminophenyl)-4-{2-[(4-methoxyphenyl)amino]-2-oxo-1-[(phenylacetyl)amino]ethyl}benzamide;

N-(2-aminophenyl)-4-{2-(2-naphthylamino)-2-oxo-1-[(phenylacetyl)amino]ethyl}benzamide;

N-(2-aminophenyl)-4-{2-[(4-methylphenyl)amino]-2-oxo-1-[(3-phenylpropanoyl)amino]ethyl}benzamide;

N-(2-aminophenyl)-4-{2-[(4-methoxyphenyl)amino]-2-oxo-1-[(3-phenylpropanoyl)amino]ethyl}benzamide;

N-(2-aminophenyl)-4-{2-(2-naphthylamino)-2-oxo-1-[(3-phenylpropanoyl)amino]ethyl}benzamide;

N-(2-aminophenyl)-4-[2-(benzylamino)-1-(4-methylpiperazin-1-yl)-2-oxoethyl]-benzamide;

N-(2-aminophenyl)-4-[2-[(4-chlorophenyl)amino]-1-(4-ethylpiperazin-1-yl)-2-oxoethyl]benzamide;

N-(2-aminophenyl)-4-[2-[(4-chlorophenyl)amino]-1-(4-methylpiperazin-1-yl)-2-oxoethyl]benzamide;

N-(2-aminophenyl)-4-[1-(4-methylpiperazin-1-yl)-2-(2-naphthylamino)-2-oxoethyl]benzamide;

N-(2-aminophenyl)-4-{2-[(4-chlorophenyl)amino]-1-[(3S)-3-methylpiperazin-1-yl]-2-oxoethyl}benzamide;

N-(2-aminophenyl)-4-[2-(2-naphthylamino)-2-oxo-1-piperazin-1-ylethyl]benzamide;

N-(2-aminophenyl)-4-[2-(2-naphthylamino)-2-oxo-1-(4-phenylpiperazin-1-yl)ethyl]benzamide;

N-(2-aminophenyl)-4-{2-(2-naphthylamino)-2-oxo-1-[4-(2-phenylethyl)piperazin-1-yl]ethyl}benzamide;

N-(2-aminophenyl)-4-[1-morpholin-4-yl-2-(2-naphthylamino)-2-oxoethyl]benzamide;

N-(2-aminophenyl)-6-{2-[(4-chlorophenyl)amino]-2-oxo-1-[(3-phenylpropanoyl)-amino]ethyl}nicotinamide;

N-(2-aminophenyl)-6-[1-(4-methylpiperazin-1-yl)-2-(2-naphthylamino)-2-oxoethyl]nicotinamide;

N-(4-aminobiphenyl-3-yl)-4-[2-[(4-chlorophenyl)amino]-1-(4-methylpiperazin-1-yl)-2-oxoethyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[2-[(4-chlorophenyl)amino]-1-(4-methylpiperazin-1-yl)-2-oxoethyl]benzamide;

N-(4-aminobiphenyl-3-yl)-6-[1-(4-methylpiperazin-1-yl)-2-(2-naphthylamino)-2-oxoethyl]nicotinamide;

N-(4-aminobiphenyl-3-yl)-6-[2-(benzylamino)-1-(4-methylpiperazin-1-yl)-2-oxoethyl]nicotinamide;

N-(4-aminobiphenyl-3-yl)-6-[2-[(4-methylphenyl)amino]-1-(4-methylpiperazin-1-yl)-2-oxoethyl]nicotinamide;

N-(4-aminobiphenyl-3-yl)-6-[2-[(4-chlorophenyl)amino]-1-(4-methylpiperazin-1-yl)-2-oxoethyl]nicotinamide;

N-(2-aminophenyl)-4-[3-[(4-chlorophenyl)amino]-2-(4-methylpiperazin-1-yl)-3-oxopropyl]benzamide;

N-(2-aminophenyl)-4-[2-(4-methylpiperazin-1-yl)-3-(2-naphthylamino)-3-oxopropyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[3-[(4-chlorophenyl)amino]-2-(4-methylpiperazin-1-yl)-3-oxopropyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[3-(benzylamino)-2-(4-methylpiperazin-1-yl)-3-oxopropyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[3-[(4-methoxyphenyl)amino]-2-(4-methylpiperazin-1-yl)-3-oxopropyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[3-[(4-methylphenyl)amino]-2-(4-methylpiperazin-1-yl)-3-oxopropyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[2-(4-methylpiperazin-1-yl)-3-(2-naphthylamino)-3-oxopropyl]benzamide;

4-{[(2-Aminophenyl)amino]carbonyl}-Nα-benzoyl-N-(4-chlorophenyl)phenyl-alaninamide;

N-(4-aminobiphenyl-3-yl)-4-[4-[(4-chlorophenyl)amino]-3-(4-methylpiperazin-1-yl)-4-oxobutyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[4-(benzylamino)-3-(4-methylpiperazin-1-yl)-4-oxobutyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[3-(4-methylpiperazin-1-yl)-4-(2-naphthylamino)-4-oxobutyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[4-[(4-methylphenyl)amino]-3-(4-methylpiperazin-1-yl)-4-oxobutyl]benzamide;

N-(4-aminobiphenyl-3-yl)-4-[4-[(4-methoxyphenyl)amino]-3-(4-methylpiperazin-1-yl)-4-oxobutyl]benzamide;

Benzyl [(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-(ethylamino)-2-oxoethyl}carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(3-thienyl)phenyl]amino}carbonyl)benzyl]-2-(ethylamino)-2-oxoethyl}carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-(methylamino)-2-oxoethyl]carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(3-thienyl)phenyl]amino}carbonyl)benzyl]-2-(methylamino)-2-oxoethyl]carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino} carbonyl)benzyl]-2-(4-methylpiperazin-1-1yl)-2-oxoethyl]carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino} carbonyl)benzyl]-2-morpholin-4-yl-2-oxoethyl]carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino} carbonyl)benzyl]-2-{[2-(dimethylamino)ethyl]amino}-2-oxoethyl]carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino} carbonyl)benzyl]-2-(benzylamino)-2-oxoethyl]carbamate;

Benzyl {(1S)-2-amino-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-oxoethyl}carbamate;

(2S)-3-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]-2-{[(benzyloxy)carbonyl]amino}propanoic acid;

Benzyl [(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-(dimethylamino)-2-oxoethyl]carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-(isopropylamino)-2-oxoethyl]carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(3-thienyl)phenyl]amino}carbonyl)benzyl]-2-oxo-2-(propylamino)ethyl]carbamate;

Benzyl [(1S)-1-[4-({[2-amino-5-(3-thienyl)phenyl]amino}carbonyl)benzyl]-2-(cyclopropylamino)-2-oxoethyl]carbamate;

Benzyl {(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-[(2-methoxylethyl)amino)-2-oxoethyl}carbamate;

Benzyl ((1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-{[2-(dimethylamino)-2-oxoethyl]amino}-2-oxoethyl)carbamate;

Benzyl {(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-[[2-(dimethylamino)-2-oxoethyl](methyl)amino]-2-oxoethyl}carbamate;

Benzyl {(1S)-2-{[2-(acetylamino)ethyl]amino}-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-oxoethyl}carbamate;

Benzyl {(1S)-2-({2-[acetyl(methyl)amino]ethyl}amino)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-oxoethyl}carbamate;

Benzyl [1(S)-(4-{[4-amino-1-phenyl-1H-pyrazol-3-yl)amino] carbonyl}benzyl)-2-(methylamino)-2-oxoethyl]carbamate;

4-[(2S)-2-(acetylamino)-3-(methylamino)-3-oxopropyl]-N-2-amino-5-(2-thienyl)phenyl]benzamide;

4-[(2S)-2-(acetylamino)-3-(4-methylpiperzin-1-yl)-3-oxopropyl]-N-2-amino-5-(2-thienyl)phenyl]benzamide;

4-[(2S)-2-(acetylamino)-3-morpholin-4-yl-3-oxopropyl]-N-2-amino-5-(2-thienyl)phenyl]benzamide;

4-[(2S)-2-(acetylamino)-3-{[2-(dimethylamino)ethyl]amino}-3-oxopropyl]-N-2-amino-5-(2-thienyl)phenyl]benzamide;

4-[(2S)-2-(acetylamino)-3-(ethylamino)-3-oxopropyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-[(2S)-2-(acetylamino)-3-(benzylamino)-3-oxopropyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

N-[2-amino-5-(2-thienyl)phenyl]-4-{(2S)-2-[(methylsulfonyl)amino]-3-morpholin-4-yl-3-oxopropyl}benzamide;

N-[2-amino-5-(2-thienyl)phenyl]-4-{(2S)-3-(ethylamino)-2-[(methylsulfonyl)amino]-3-oxopropyl}benzamide;

N-[2-amino-5-(2-thienyl)phenyl]-4-{(2S)-3-(benzylamino)-2-[(methylsulfonyl)amino]-3-oxopropyl}benzamide;

pyridin-3-ylmethyl[(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-(ethylamino)-2-oxoethyl]carbamate;

pyridin-3-ylmethyl[(1S)-1-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)benzyl]-2-(methylamino)-2-oxoethyl]carbamate;

N-[(1S)-1-[4-({[2-amino-5-(3-thienyl)phenyl]amino}carbonyl)benzyl]-2-oxo-2-(propylamino)ethyl]thiophene-2-carboxamide;

4-[(2S)-2-amino-3-(ethylamino)-3-oxopropyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-[(2S)-2-amino-3-(methylamino)-3-oxopropyl]-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-((2S)-2-amino-3-{[2-(dimethylaminoethyl]amino}-3-oxopropyl)-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

4-{(2S)-2-amino-3-[(2-methoxyethyl)amino]-3-oxopropyl}-N-[2-amino-5-(2-thienyl)phenyl]benzamide;

2-amino-3-[4-({[2-amino-5-(3-thienyl)phenyl]amino}carbonyl)phenyl]propanoic acid;

Ethyl 3-[4-({[2-amino-5-(2-thienyl)phenyl]amino}carbonyl)phenyl]-2-(dimethylamino)propanoate;

4-[1-(acetylamino)-2-amino-2-oxoethyl]-N-[2-(acetylamino)-5-(2-thienyl)phenyl]benzamide;

N-[2-amino-5-(2-thienyl)phenyl]-4-{2-(methylamino)-1-[(methylsulfonyl)amino]-2-oxoethyl}benzamide;

N-[2-amino-5-(2-thienyl)phenyl]-4-(2-(methylamino)-1-{[(methylamino)carbonyl]amino}-2-oxoethyl)benzamide;

4-{1-[(Acetylamino)methyl]-2-anilino-2-oxoethyl}-N-[2-amino-5-(3-thienyl)phenyl]benzamide;

N-[2-Amino-5-(3-thienyl)phenyl]-4-[2-anilino-1-({[(methylamino)carbonyl]amino} methyl)-2-oxo-ethyl]benzamide;

N-[2-Amino-5-(3-thienyl)phenyl]-4-{2-anilino-1-[(dimethylamino)methyl]-2-oxoethyl}benzamide;

4-{1-[(acetylamino)methyl]-2-anilino-2-oxoethyl}-N-[2-amino-5-(3-thienyl)phenyl]benzamide;

4-[1-[(acetylamino)methyl]-2-(methylamino)-2-oxoethyl]-N-[2-amino-5-(3-thienyl)phenyl]benzamide;

4-[1-[(acetylamino)methyl]-2-(dimethylamino)-2-oxoethyl]-N-[2-amino-5-(3-thienyl)phenyl]benzamide;

4-{1-[(acetylamino)methyl]-2-morpholin-4-yl-2-oxoethyl}-N-[2-amino-5-(3-thienyl)phenyl]benzamide;

N-[2-amino-5-(3-thienyl)phenyl]-4-{2-anilino-1-[(dimethylamino)methyl]-2-oxoethyl}benzamide;

N-[2-amino-5-(3-thienyl)phenyl]-4-[1-[(dimethylamino)methyl]-2-(methylamino)-2-oxoethyl]benzamide;

N-[2-amino-5-(3-thienyl)phenyl]-4-(2-anilino-1-{[(methylsulfonyl)amino]methyl}-2-oxoethyl)benzamide;

N-[2-amino-5-(3-thienyl)phenyl]-4-(2-(methylamino)-1-{[(methylsulfonyl)amino]methyl}-2-oxoethyl)benzamide;

N-[2-amino-5-(3-thienyl)phenyl]-4-(2-(dimethylamino)-1-{[(methylsulfonyl)amino]methyl}-2-oxoethyl)benzamide;

N-[2-amino-5-(3-thienyl)phenyl]-4-[2-anilino-1-({[(methylamino)carbonyl]amino}methyl)-2-oxoethyl]benzamide;

N-[2-amino-5-(3-thienyl)phenyl]-4-[2-(methylamino)-1-({[(methylamino)carbonyl]amino}methyl)-2-oxoethyl]benzamide;

N-[2-amino-5-(3-thienyl)phenyl]-4-[2-(dimethylamino)-1-({[(methylamino)carbonyl]amino}methyl)-2-oxoethyl]benzamide; and

[4-({[2-[(tert-butoxycarbonyl)amino]-5-(2-thienyl)phenyl]amino}carbonyl)phenyl] (pyrrolidin-1-yl)acetic acid;

or a stereoisomer or a pharmaceutically acceptable salt thereof.

6. A pharmaceutical composition comprising a pharmaceutically effective amount of the compound according to claim 1 , and a pharmaceutically acceptable carrier.

7. A method of treating neoplastic cancer or tumor in a mammal comprising the step of administering a therapeutically effective amount of the compound of claim 1 in the mammal.

Assignments (5)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
CHANGE OF NAME Recorded Jan 26, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023845/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2009
From: GRIMM, JONATHAN B; HUBBS, JED L; MILLER, THOMAS; OTTE, KARIN M; SILIPHAIVANH, PHIENG; STANTON, MATTHEW G; WILSON, KEVIN; WITTER, DAVID; ZHOU, HUA
To: MERCK & CO., INC.
Reel/Frame 022549/0209 →